115 related articles for article (PubMed ID: 430364)
1. Dopaminergic control of the septal-hippocampal cholinergic pathway.
Robinson SE; Malthe-Sørenssen D; Wood PL; Commissiong J
J Pharmacol Exp Ther; 1979 Mar; 208(3):476-9. PubMed ID: 430364
[TBL] [Abstract][Full Text] [Related]
2. Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition.
Elvander E; Schött PA; Sandin J; Bjelke B; Kehr J; Yoshitake T; Ogren SO
Neuroscience; 2004; 126(3):541-57. PubMed ID: 15183504
[TBL] [Abstract][Full Text] [Related]
3. The septal-hippocampal cholinergic pathway: role in antagonism of pentobarbital anesthesia and regulation by various afferents.
Brunello N; Cheney DL
J Pharmacol Exp Ther; 1981 Nov; 219(2):489-95. PubMed ID: 6793716
[No Abstract] [Full Text] [Related]
4. Modulation of acetylcholine metabolism in the hippocampal cholinergic pathway by intraseptally injected substance P.
Malthe-Sphirenssen D; Cheney DL; Costa E
J Pharmacol Exp Ther; 1978 Jul; 206(1):21-8. PubMed ID: 660551
[TBL] [Abstract][Full Text] [Related]
5. Interaction between impulse-flow and delta 9-tetrahydrocannabinol within the septal-hippocampal cholinergic pathway of rat brain.
Lindamood C; Colasanti BK
J Pharmacol Exp Ther; 1981 Nov; 219(2):580-4. PubMed ID: 6270316
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by repeated lithium treatment in rats.
Fujii T; Nakai K; Nakajima Y; Kawashima K
Can J Physiol Pharmacol; 2000 May; 78(5):392-9. PubMed ID: 10841434
[TBL] [Abstract][Full Text] [Related]
7. [Improvement in spontaneous and acquired spatial behaviors following lesions of septal dopaminergic afferents in mice: possible relations with hippocampal cholinergic activity].
Galey D; Durkin T; Sifakis G; Jaffard R
C R Acad Sci III; 1984; 299(16):681-6. PubMed ID: 6440670
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the turnover rate of hippocampal acetylcholine by neuropeptides: possible site of action of alpha-melanocyte-stimulating hormone, adrenocorticotrophic hormone and somatostatin.
Wood PL; Cheney DL; Costa E
J Pharmacol Exp Ther; 1979 Apr; 209(1):97-103. PubMed ID: 219181
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic regulation of cortical acetylcholine release.
Day J; Fibiger HC
Synapse; 1992 Dec; 12(4):281-6. PubMed ID: 1465741
[TBL] [Abstract][Full Text] [Related]
10. Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors.
Gobert A; Di Cara B; Cistarelli L; Millan MJ
J Pharmacol Exp Ther; 2003 Apr; 305(1):338-46. PubMed ID: 12649387
[TBL] [Abstract][Full Text] [Related]
11. Pro- and anti-apoptotic evidence for cholinergic denervation and hippocampal sympathetic ingrowth in rat dorsal hippocampus.
Harrell LE; Parsons DS; Kolasa K
Exp Neurol; 2005 Jul; 194(1):182-90. PubMed ID: 15899255
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin-type 1 receptors in rat brain.
Quirion R; Richard J
Synapse; 1987; 1(1):124-30. PubMed ID: 3145578
[TBL] [Abstract][Full Text] [Related]
13. Impaired and spared cholinergic functions in the hippocampus after lesions of the medial septum/vertical limb of the diagonal band with 192 IgG-saporin.
Chang Q; Gold PE
Hippocampus; 2004; 14(2):170-9. PubMed ID: 15098723
[TBL] [Abstract][Full Text] [Related]
14. Chronic effects of traumatic brain injury on hippocampal vesicular acetylcholine transporter and M2 muscarinic receptor protein in rats.
Ciallella JR; Yan HQ; Ma X; Wolfson BM; Marion DW; DeKosky ST; Dixon CE
Exp Neurol; 1998 Jul; 152(1):11-9. PubMed ID: 9682008
[TBL] [Abstract][Full Text] [Related]
15. Septohippocampal cholinergic changes after destruction of the A10-septal dopaminergic pathways.
Yanai J; Rogel-Fuchs Y; Pick CG; Slotkin T; Seidler FJ; Zahalka EA; Newman ME
Neuropharmacology; 1993 Feb; 32(2):113-7. PubMed ID: 8450940
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of dopamine on acetylcholine release from caudate nucleus.
Vizi SE; Rónai A; Hársing L; Knoll J
Pol J Pharmacol Pharm; 1977; 29(3):201-11. PubMed ID: 887499
[TBL] [Abstract][Full Text] [Related]
17. Interelationships between dopaminergic and cholinergic systems in the cerebral cortex.
Mantovani P; Bartolini A; Pepeu G
Adv Biochem Psychopharmacol; 1977; 16():423-7. PubMed ID: 883550
[No Abstract] [Full Text] [Related]
18. Modulation by dopaminergic and serotonergic systems of cholinergic interneurons in nucleus accumbens and striatum.
Bluth R; Langnickel R; Ott T
Pol J Pharmacol Pharm; 1985; 37(6):753-63. PubMed ID: 3832017
[TBL] [Abstract][Full Text] [Related]
19. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
[TBL] [Abstract][Full Text] [Related]
20. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions.
Laplante F; Srivastava LK; Quirion R
J Neurochem; 2004 Apr; 89(2):314-23. PubMed ID: 15056275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
